1. Home
  2. HUIZ vs LNAI Comparison

HUIZ vs LNAI Comparison

Compare HUIZ & LNAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huize Holding Limited

HUIZ

Huize Holding Limited

N/A

Current Price

$1.34

Market Cap

13.4M

Sector

Finance

ML Signal

N/A

Logo Lunai Bioworks Inc.

LNAI

Lunai Bioworks Inc.

N/A

Current Price

$1.42

Market Cap

12.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HUIZ
LNAI
Founded
2006
N/A
Country
China
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.4M
12.4M
IPO Year
2019
2014

Fundamental Metrics

Financial Performance
Metric
HUIZ
LNAI
Price
$1.34
$1.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
31.0K
★ 36.4K
Earning Date
08-20-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.48
N/A
Revenue Next Year
$6.59
N/A
P/E Ratio
$7.81
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.04
$0.15
52 Week High
$4.16
$5.02

Technical Indicators

Market Signals
Indicator
HUIZ
LNAI
Relative Strength Index (RSI) 44.91 25.99
Support Level $1.17 $0.26
Resistance Level $1.55 $2.58
Average True Range (ATR) 0.08 0.25
MACD -0.02 -0.08
Stochastic Oscillator 17.07 7.39

Price Performance

Historical Comparison
HUIZ
LNAI

About HUIZ Huize Holding Limited

Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners. Geographically, the company is concentrated in PRC Mainland, Hong Kong and others segments.

About LNAI Lunai Bioworks Inc.

Lunai Bioworks Inc is a biopharmaceutical company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or life-long cancer remission in some of the deadliest cancers. The group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics to provide earlier and more accurate cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. The group's reportable segments are: RENB, BioSymetrics, and RENC. Geographically, it operates in the United States and Netherlands.

Share on Social Networks: